KDM4C and lung carcinoma: The aberrantly high expression of KDM4C in lung cancer inhibits CXCL10 transcription by reducing the enrichment of activated histone H3K36me3 at the CXCL10 promoter region, thus decreasing the infiltration and activation of CD8+ T cells.